# Calcitonin (Salmon)

Canonical source: https://retacompare.com/encyclopedia/calcitonin

Inhibits osteoclast bone resorption; mild analgesic effect on bone pain.

Reference facts

Also known asMiacalcin, Fortical, SalcatoninCategoryBone & CalciumMechanism of actionInhibits osteoclast bone resorption; mild analgesic effect on bone pain.TargetsCalcitonin receptorIndications under research or approvedOsteoporosis (post-menopausal, ≥5y post), Paget's disease of bone, Hypercalcemia of malignancyRegulatory status (reference entry)FDA-approved (1986; FDA 2013 advisory restricted use due to malignancy signal)Half-life~20 minutes (subcutaneous); shorter intranasalSequenceCSNLSTCVLGKLSQELHKLQTYPRTNTGSGTPSequence notes32-residue peptide with disulfide bridge Cys1-Cys7 and C-terminal amide. Salmon calcitonin is ~50× more potent than human calcitonin in humans.Molecular weight (Da)3432PDB accession2GLHFirst reported1962
    Primary References

Miacalcin FDA label


    Explore research articles about Calcitonin (Salmon)


    This is an educational reference, not medical advice. Research findings do not establish safety or efficacy for self-administration. Consult the primary sources for study populations, limitations, and current regulatory status.

## Sources

- Miacalcin FDA label: https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/021406s006lbl.pdf